Roche struck a cancer drug licensing deal with China's Hansoh that could exceed $15 billion Oct 19, 2026 · Cris Tolomia Hansoh will receive $400 million upfront and keep rights to the programs in mainland China, Hong Kong, Macau and Taiwan Read more »